Unlock instant, AI-driven research and patent intelligence for your innovation.

Hepatocellular carcinoma sorafenib-resistant cell strain and construction method thereof

A technology of human liver cancer cell lines and drug-resistant cells, applied in the field of biomedicine, can solve the problems of lack of liver cancer cell lines and drug resistance of patients, and achieve the effect of high scientific research and production application value.

Inactive Publication Date: 2014-07-30
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, only a considerable number of patients in the patient population are not sensitive to sorafenib, and sensitive patients often have drug resistance after sorafenib treatment
However, there is still a lack of liver cancer cell lines resistant to Sorafenib, and the method for constructing tumor drug-resistant cell lines needs to be improved urgently.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hepatocellular carcinoma sorafenib-resistant cell strain and construction method thereof
  • Hepatocellular carcinoma sorafenib-resistant cell strain and construction method thereof
  • Hepatocellular carcinoma sorafenib-resistant cell strain and construction method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Example 1: Validation of induction and establishment of LM3 / SORA cells of drug-resistant liver cancer

[0033] ① After resuscitating LM3 cells of human liver cancer cell line, use DMEM culture medium containing 10% fetal bovine serum at 37℃, 5% CO 2 Cultivate in an incubator. The LM3 cells in the logarithmic growth phase were seeded in a 24-well plate. In order to find the maximum drug-resistant concentration of cells that can tolerate sorafenib (the concentration at which cells can survive and grow slowly), add sorafenib to each culture well to the final concentration of 0.5μmol / L and 1μmol / L, respectively , 2μmol / L, 5μmol / L, 10μmol / L, 15μmol / L, 20μmol / L, passage or change in time.

[0034] After each passage or fluid change, Sorafenib was added to the original concentration and treated continuously for 3 months. The maximum drug resistance concentration at which cells can survive and grow slowly after the addition of sorafenib is the screening concentration.

[0035] ② Th...

Embodiment 2

[0037] Example 2: Morphological observation of LM3 / SORA cells of the drug-resistant liver cancer strain

[0038] (1) Observe the morphology of living cells with an inverted phase-contrast microscope: Take LM3 control cells and LM3 / SORA resistant cells in logarithmic growth phase, wash with saline and change the solution, and observe the morphology of living cells under an inverted microscope (×200 times). Through the light microscope, it can be observed that the LM3 cells are basically the same size, polypseudopod-like polygons, and some are round (such as figure 2 a); and LM3 / SORA cells are of different sizes, round and polygonal, and the polygonal shapes are different (such as figure 2 b).

Embodiment 3

[0039] Example 3: Determination of the growth curve of LM3 / SORA cells of the drug-resistant liver cancer strain

[0040] Take LM3 and LM3 / SORA cells in logarithmic growth phase, digest with 0.5% trypsin and count them, inoculate into a 96-well plate at a density of 5000 cells per well and set up 3 multiple wells, add 200μL medium to each well , Placed at 37℃, 5% CO 2 Incubate in an incubator for 0h, 24h, 48h, 72h, 96h; aspirate the medium at each time point, add 100μL of CCK8 working solution to each well, incubate in the incubator for 1 hour, put it in the microplate reader and measure at 450nm wavelength , Read the OD value of each well and calculate the average value, draw the growth curve with time as the abscissa and the average OD value as the ordinate.

[0041] After continuously testing the growth status of the two cells, it is found that the drug-resistant cell line LM3 / SORA has a faster proliferation rate than the normal tumor cell line LM3, and the curve is still upward ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of biomedicines and specifically relates to a hepatocellular carcinoma sorafenib-resistant cell strain and a construction method thereof. A human hepatocellular carcinoma sorafenib-resistant strain LM3 / SORA which can grow rapidly under the treatment of sorafenib can be further obtained by taking a human hepatocellular carcinoma cell strain MHCC-LM3 as an inducing object, utilizing sorafenib with different concentrations for performing continuous treatment for 3 months, seeking maximum drug-resistant concentration which can enable the cells to survive and grow slowly and performing continuous treatment on the LM3 cells for 4 months by taking the concentration as screening concentration. The hepatocellular carcinoma sorafenib-resistant cell strain provided by the invention has important application prospects in the aspects of researching a hepatoma drug-resistant mechanism, reversing drug resistance of hepatoma cells and guiding medication of patients.

Description

Technical field [0001] The present invention relates to the field of biomedical technology, in particular to a sorafenib drug-resistant cell line of hepatocellular carcinoma and a construction method thereof. Background technique [0002] Primary liver cancer is one of the most common malignant tumors in the world. Its incidence ranks sixth among malignant tumors and its mortality rate ranks third. Most patients with liver cancer are already in the middle and advanced stages when they are discovered, and they have lost the opportunity for surgery and require medication. The postoperative recurrence and metastasis rate of liver cancer patients is very high, and a considerable number of patients still need timely drug treatment after surgery. [0003] Drug therapy is one of the important methods for the treatment of liver cancer, but drug resistance often appears in patients during the treatment process, which is the main reason for the failure of drug therapy. Therefore, it is ver...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/09C12Q1/02C12R1/91
Inventor 王红阳丁劲李恒宇程卓孙文陈程
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY